We live in the era of the access revolution. We have come to expect access to information, services, and products whenever they are available, wherever they are available. And we expect access to be convenient, transparent and dependable. Many industries, including travel, culture, retail, entertainment, and education, have been profoundly changed by this revolution. Earlier access to medicines is an area now on the verge of similar change. myTomorrows is a technology driven life sciences service company transforming how patients, Doctors and pharmaceutical companies access medicines and information through its unique on-line platform.
Business model IV: Digital revolution company
Wednesday June 24th, 09:30 - 10:30
About Steve Glass
Steve joined the Pharmaceutical Industry as a sales representative after leaving university in the UK. He quickly moved into marketing and management roles in the UK before his first senior international assignment as Country Manager, Portugal for Schering-Plough. He has held senior international roles for major pharma and biotech companies, such as Biomarin, Altana (now part of Takeda) and the Clinigen Group. He has also advised Edmond de Rothschild Partners on private equity pharma transactions. He now is the COO of the Dutch based tech enabled life science company, myTomorrows; a company fundamentally changing the way patients access medicines in development.
Jumpstart your career
Join BioBusiness Summer School to jumpstart your career in Life Sciences by gaining knowledge of business aspects such as product development, IPR, finance and business models. The next edition of the summer school will be announced soon!
The BioBusiness Summer School is a programme tailored to bridge the gap. By immersing yourself in the business aspects of Life Sciences during this programme, you will learn the basic knowledge of BioBusiness, gain insight in the world of Life Sciences companies, meet leading business leaders and increase your international network.